BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 15721863)

  • 1. Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes.
    Planavila A; Rodríguez-Calvo R; Jové M; Michalik L; Wahli W; Laguna JC; Vázquez-Carrera M
    Cardiovasc Res; 2005 Mar; 65(4):832-41. PubMed ID: 15721863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1.
    Barroso E; Eyre E; Palomer X; Vázquez-Carrera M
    Biochem Pharmacol; 2011 Feb; 81(4):534-43. PubMed ID: 21146504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.
    Gilde AJ; van der Lee KA; Willemsen PH; Chinetti G; van der Leij FR; van der Vusse GJ; Staels B; van Bilsen M
    Circ Res; 2003 Mar; 92(5):518-24. PubMed ID: 12600885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy.
    Planavila A; Laguna JC; Vázquez-Carrera M
    J Biol Chem; 2005 Apr; 280(17):17464-71. PubMed ID: 15728586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
    Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
    Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin prevents peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) downregulation in lipopolysaccharide-stimulated H9c2 cells.
    Planavila A; Sánchez RM; Merlos M; Laguna JC; Vázquez-Carrera M
    Biochim Biophys Acta; 2005 Sep; 1736(2):120-7. PubMed ID: 16139565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation.
    Planavila A; Iglesias R; Giralt M; Villarroya F
    Cardiovasc Res; 2011 May; 90(2):276-84. PubMed ID: 21115502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cardiac hypertrophy by triflusal (4-trifluoromethyl derivative of salicylate) and its active metabolite.
    Planavila A; Rodríguez-Calvo R; de Arriba AF; Sánchez RM; Laguna JC; Merlos M; Vazquez-Carrera M
    Mol Pharmacol; 2006 Apr; 69(4):1174-81. PubMed ID: 16421291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
    Liu J; Xia Q; Zhang Q; Li H; Zhang J; Li A; Xiu R
    Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of peroxisome proliferator-activated receptor-beta/delta in epidermal growth factor-induced HaCaT cell proliferation.
    Liang P; Jiang B; Yang X; Xiao X; Huang X; Long J; Zhang P; Zhang M; Xiao M; Xie T; Huang X
    Exp Cell Res; 2008 Oct; 314(17):3142-51. PubMed ID: 18625220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist-induced activation releases peroxisome proliferator-activated receptor beta/delta from its inhibition by palmitate-induced nuclear factor-kappaB in skeletal muscle cells.
    Jové M; Laguna JC; Vázquez-Carrera M
    Biochim Biophys Acta; 2005 May; 1734(1):52-61. PubMed ID: 15866483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid.
    Rieck M; Meissner W; Ries S; Müller-Brüsselbach S; Müller R
    Mol Pharmacol; 2008 Nov; 74(5):1269-77. PubMed ID: 18701617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure.
    Letavernier E; Perez J; Joye E; Bellocq A; Fouqueray B; Haymann JP; Heudes D; Wahli W; Desvergne B; Baud L
    J Am Soc Nephrol; 2005 Aug; 16(8):2395-402. PubMed ID: 15944338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of peroxisome proliferator-activated receptor isoforms alpha, beta/delta, and gamma mediate distinct facets of hypertrophic transformation of adult cardiac myocytes.
    Pellieux C; Montessuit C; Papageorgiou I; Lerch R
    Pflugers Arch; 2007 Dec; 455(3):443-54. PubMed ID: 17643263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Globular adiponectin inhibits angiotensin II-induced nuclear factor kappaB activation through AMP-activated protein kinase in cardiac hypertrophy.
    Wang C; Li L; Zhang ZG; Fan D; Zhu Y; Wu LL
    J Cell Physiol; 2010 Jan; 222(1):149-55. PubMed ID: 19780028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MyD88-dependent nuclear factor-kappaB activation is involved in fibrinogen-induced hypertrophic response of cardiomyocytes.
    Li T; Wang Y; Liu C; Hu Y; Wu M; Li J; Guo L; Chen L; Chen Q; Ha T; Li C; Li Y
    J Hypertens; 2009 May; 27(5):1084-93. PubMed ID: 19342961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-alpha.
    Pellieux C; Montessuit C; Papageorgiou I; Lerch R
    Cardiovasc Res; 2009 May; 82(2):341-50. PubMed ID: 19131364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARbeta/delta activation inhibits angiotensin II-induced collagen type I expression in rat cardiac fibroblasts.
    Zhang H; Pi R; Li R; Wang P; Tang F; Zhou S; Gao J; Jiang J; Chen S; Liu P
    Arch Biochem Biophys; 2007 Apr; 460(1):25-32. PubMed ID: 17346664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2.
    Rodríguez-Calvo R; Serrano L; Coll T; Moullan N; Sánchez RM; Merlos M; Palomer X; Laguna JC; Michalik L; Wahli W; Vázquez-Carrera M
    Diabetes; 2008 Aug; 57(8):2149-57. PubMed ID: 18443198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.